Mouse Skeletal Muscle Myoblasts (MSkMM)

Overview

Mouse Skeletal Muscle Myoblasts (MSkMM) is a cell model used for research applications where physiologically relevant identity and donor background support interpretation of experimental readouts. Mouse Myoblasts derived from Skeletal Muscle (Skeletal Muscle) within the Musculoskeletal system.

Myoblast is a type of progenitor cells that differentiates to give rise to muscle cells [1] . They are the main effector cells in the myogenesis by fusing with each other to injured myofibers leading to the formation of new myofibers or regenerations of skeletal muscle in adults [2] . Many steps of myogenesis can be recapitulated through in vitro differentiation of myoblasts into myotubes. Primary myoblasts have been suggested as the most physiologically relevant model for studying myogenesis in vitro [3] . MSkMM from iXCells Biotechnologies are derived from mouse skeletal satellite cells isolated from mouse gastrocnemius (GA) and tibialis anterior (TA) muscles of both hind limbs by culturing them on matrigel-coated plastic dishes (Figure 1). MSkMM are cryopreserved at passage one and delivered frozen. Each vial contains ≥5 x 10 5 cells/vial. MSkMM are characterized by immunofluorescence with antibodies specific to MyoD and Desmin (Figure 2). MSkMM can be in vitro differentiated into myotube using Mouse Skeletal Muscle Myoblast Differentiation Medium ( Cat#MD-0065 ). MSkMM are guaranteed to further expand two passages using the culture medium provided by iXCells. These cells are negative for mycoplasma, bacteria, yeast and fungi. Figure 1. Mouse Skeletal Muscle Myoblasts (MSkMM) were recovered and seeded at 1X10 4 /cm 2 in Mouse Skeletal Muscle Myoblast Growth Medium (Cat# MD-0064). Phase contrast images were taken at the indicated time post recovery.

Key elements and design rationale

• Cell identity: Myoblasts (Primary Cells)
• Source context: Skeletal Muscle; Skeletal Muscle; Musculoskeletal
• Biosafety level: BSL-1 (follow your institution’s biosafety program and local regulations)

Product-specific elements (such as tissue source, donor background, and cell classification) help frame how results should be interpreted across assays and experimental conditions.

Biological background

Cells originating from the Musculoskeletal system are commonly studied to understand tissue-specific physiology, signaling, and responses to perturbations in controlled in vitro settings.

Across primary and specialty cell models, experimental outcomes can be influenced by donor heterogeneity, passage history, confluence, and media composition. For interpretation, it is common to validate key markers or functional phenotypes in the user’s assay context and to document culture variables consistently.

Research relevance and current trends

• Increasing use of primary and specialty cells to improve translational relevance for target biology and phenotypic screening.
• Adoption of 3D culture formats and co-culture systems to better capture tissue microenvironments and cell–cell interactions.
• Integration of functional readouts with single-cell and multi-omics profiling to connect phenotype with molecular state.

Common research applications

• Profile identity markers by flow cytometry or immunostaining in cultured cells
• Quantify functional responses to defined stimuli relevant to the model system
• Compare baseline phenotype across donors/conditions using gene expression profiling
• Evaluate matrix remodeling and differentiation programs in musculoskeletal cell models
• Screen compounds or genetic perturbations for phenotype modulation using viability or imaging endpoints

Interpretation typically focuses on how a perturbation (e.g., cytokine exposure, metabolic stress, genetic manipulation, or compound treatment) shifts marker profiles or functional readouts relative to an appropriate control matched for donor and culture variables.

Notes for experimental interpretation

• Donor-to-donor heterogeneity can influence baseline phenotype and treatment response; include biological replicates when feasible.
• Passage number, confluence, and media composition can shift gene expression and functional readouts; track and report these variables consistently.
• Contamination control (including routine mycoplasma monitoring) supports reproducibility in downstream assays.
• Use appropriate negative/positive controls for the readout (e.g., unstimulated controls, pathway agonists/antagonists) to contextualize observed changes.

SKU:BHC18500093

Customization & Add-ons: Can't find the cell line you need—or require a custom cell-based solution for your project? We can help you source the best match or support custom cell line services for diverse research needs, including cell line sourcing and selection (species, tissue, and disease model matching), stable cell line engineering (overexpression, knockdown, or knockout via CRISPR/Cas9, shRNA, or sgRNA), reporter gene integration (GFP, RFP, luciferase, and other fluorescent or bioluminescent constructs), genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles), inducible expression systems (Tet-On/Off and other regulatable constructs), drug resistance marker selection (puromycin, G418, hygromycin, and others), custom growth and media optimisation for specific assay requirements, scale-up production for high-throughput screening campaigns, and authentication and QC services (STR profiling, mycoplasma testing, viability assessment). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.